Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › MNPR

DEERFIELD MANAGEMENT COMPANY, L.P. position in MNPR

MONOPAR THERAPEUTICS INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 323,745 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$30.0M, representing 0.38% of its reported portfolio and ranking #49 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)323.75K sh
Reported value held$29.98M
Portfolio Weight0.38%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s MNPR position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in MNPR in Q3 2025 at 159,765 shares (US$13.0M). The position peaked in Q2 2026 at 323,745 shares, worth US$30.0M. Across 4 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 323,745 shares valued at US$30.0M. Notable position changes include a 90% increase in Q1 2026 (shares rose 69% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 159.76K $13.05M New
Q4 2025 170.56K $11.14M Add
Q1 2026 323.75K $17.74M Add
Q2 2026 323.75K $29.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MNPR and 13F data

MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), Saturn V Capital Management LP (US$28.9M), Siren, L.L.C. (US$25.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MNPR

All MNPR fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held MNPR?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in MNPR?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 323.75K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $29.98M, representing 0.38% of its reported portfolio and ranking #49.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling MNPR?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in MNPR. The position peaked in Q2 2026 at 323.75K shares.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., Saturn V Capital Management LP, Siren, L.L.C., among 84 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.